Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharpe, J. A.
Right arrow Articles by Zackon, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharpe, J. A.
Right arrow Articles by Zackon, D. H.
NEUROLOGY 1987;37:1389
© 1987 American Academy of Neurology

Smooth pursuit during dose-related on-off fluctuations in Parkinson's disease

James A. Sharpe, MD, William A. Fletcher, MD, Anthony E. Lang, MD and David H. Zackon, MD

Division of Neurology and the Playfair Neuroscience Unit, The Toronto Hospital and the Departments of Medicine and Ophthalmology, University of Toronto, Toronto, Ontario, Canada.

Smooth pursuit was studied during predictable L-dopa dose-related "OR" periods of morning akinesia and wearing off and during "on" periods in eight patients with idiopathic Parkinson's disease. Smooth pursuit gain was significantly reduced in patients during both on and off phases. Despite marked fluctuations between parkinsonism and periods of near normal skeletal motion, there were no changes in smooth pursuit gain. We conclude that unvarying paresis of smooth pursuit in Parkinson's disease signifies involvement of neural circuits that are distinct from the dopaminergic mechanisms that mediate the on-off phenomenon of somatic motor control.

Address correspondence and reprint requests to Dr. Sharpe, Division of Neurology, The Toronto Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

Supported by the Medical Research Council of Canada grants MT5404 and ME5509 (Dr. Sharpe), an Alberta Heritage Foundation for Medical Research Fellowship (Dr. Fletcher) and the E.A. Baker Foundation, Canadian National Institute for the Blind (Dr. Zackon).

Presented in part at the thirty-eighth annual meeting of the American Academy of Neurology, New Orleans, LA, April 1986.

Received September 25, 1986. Accepted for publication in final form November 19, 1986.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Jankovic
Parkinson's disease: clinical features and diagnosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D.-M. Cui, Y.-J. Yan, and J. C. Lynch
Pursuit Subregion of the Frontal Eye Field Projects to the Caudate Nucleus in Monkeys
J Neurophysiol, May 1, 2003; 89(5): 2678 - 2684.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G U Lekwuwa, G R Barnes, C J S Collins, and P Limousin
Progressive bradykinesia and hypokinesia of ocular pursuit in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 1999; 66(6): 746 - 753.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.